http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014057108-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bbdef915d9b6d448a1b86edc7493230
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bed055005428d4d0ceba2f810038f93
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1716
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 2013-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e122284c87f52320b9c435977f6e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43c4405180f16d38a4981ae461ee56bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73fd2816e6fba2d44e222db98348362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e9c6e2f3658b0918c9021923afaf94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ce467ee96ef823651a607f220b0f90
publicationDate 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014057108-A1
titleOfInvention Serum amyloid p-component as a therapeutic agent or biomarker
abstract The present invention relates to the treatment of inflammatory diseases and in particular to the provision of therapeutic agents which may halt or slow the progression of inflammatory diseases or disorders. Such diseases include fibrosis, hypertrophy and cardiovascular inflammatory conditions. In particular the agent may be used to halt or slow the progression of hypertensive heart disease into heart failure with preserved ejection fraction. A suitable therapeutic agent is Serum Amyloid P-component. The invention also relates to the use of Serum Amyloid P-component as a biomarker in diagnosing or monitoring the progression of such diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2750642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11402378-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017184726-A3
priorityDate 2012-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007065368-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127522966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128636063

Total number of triples: 24.